Sigilon Therapeutics, Inc.
Sigilon Therapeutics, Inc. (SGTX) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 22 transactions totaling $33.1M, demonstrating a bullish sentiment with $29.0M in net insider flow. The most recent transaction on Aug 11, 2023 involved a transaction of 3,504 shares valued at $0.
SGTX Insider Activity Summary
Who Is Buying SGTX Stock?
No significant insider buying has been recorded for SGTX in the recent period.
Who Is Selling SGTX Stock?
No significant insider selling has been recorded for SGTX in the recent period.
Is Sigilon Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SGTX is bullish with an Insider Alignment Score of 94/100 and a net flow of $29.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
SGTX Frequently Asked Questions
Understanding SGTX Insider Activity
Insider trading at Sigilon Therapeutics, Inc. (SGTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading SGTX stock, having executed 22 transactions in the past 90 days. The most active insider is Acquisition Corp Shenandoah (Executive), who has made 1 transactions totaling $25.6M.
Related Tools
Track Sigilon Therapeutics, Inc. Insider Activity
Get notified when executives and directors at SGTX file new Form 4 transactions